MethodAdded (g mL-1 )BCGBTB5.0 ten 15 five.0 10Recovery 99.ten one hundred.20 99.40 99.30

June 25, 2023

MethodAdded (g mL-1 )BCGBTB5.0 ten 15 five.0 10Recovery 99.ten one hundred.20 99.40 99.30 99.50 one hundred.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE
MethodAdded (g mL-1 )BCGBTB5.0 10 15 five.0 10Recovery 99.ten one hundred.20 99.40 99.30 99.50 one hundred.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE -0.90 0.20 -0.60 -0.70 -0.50 0.50 Self-assurance limitb 4.955 0.021 ten.02 0.078 14.91 0.173 4.965 0.026 9.95 0.09 20.ten 0.231 Recovery 99.60 99.80 99.20 one hundred.60 99.40 99.Precision RSD a 0.51 0.75 1.02 0.40 0.68 0.Interday Accuracy RE -0.40 0.20 -0.80 0.60 -0.60 -0.Self-assurance limitb four.98 0.025 9.98 0.075 14.88 0.152 5.03 0.020 9.94 0.068 19.92 0.abMean of six determinations; RSD : percentage relative regular deviation; RE : percentage relative error. Self-confidence limit at 95 confidence level and five degrees of freedom ( = 2.571).Journal of Analytical Solutions in ChemistryJournal of Analytical RelA/p65 supplier Methods in ChemistryTable five: Determination of GMF in its pharmaceutical dosage types applying the typical addition method.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )2.BCG2.BCP2.BPB2.BTB5.MO4.0 8.0 12 2.0 six.0 ten four.0 eight.0 12 4.0 8.0 12 five.0 10Factive 5-HT3 Receptor Antagonist list tablets Flobiotic tablet GemiQue tablets Total found (g mL-1 ) Recovery a SD Total discovered (g mL-1 ) Recovery SD Total identified (g mL-1 ) Recovery SD five.96 99.30 0.78 5.98 99.60 0.67 6.02 100.30 0.51 9.91 99.ten 1.02 10.02 one hundred.20 0.82 9.92 99.20 0.70 13.97 99.80 1.24 13.96 99.70 1.09 13.99 99.90 0.94 three.996 99.90 0.66 3.96 99.10 0.42 3.97 99.30 0.38 8.02 100.20 0.90 7.98 99.80 0.69 7.99 99.90 0.84 11.92 99.30 0.95 12.05 one hundred.40 1.03 11.95 99.60 1.17 5.97 99.50 0.57 5.99 99.80 0.36 6.01 one hundred.15 0.76 9.97 99.70 0.76 9.96 99.60 0.49 9.97 99.70 0.96 13.87 99.ten 1.14 13.97 99.90 0.78 13.89 99.20 1.21 six.03 100.50 0.48 six.01 one hundred.ten 0.53 six.01 100.10 0.54 9.90 99.00 0.72 9.96 99.60 0.85 9.96 99.60 1.03 13.93 99.50 0.97 13.96 99.70 1.31 14.04 one hundred.30 1.15 9.97 99.70 0.32 9.91 99.ten 0.70 9.99 99.90 0.65 14.94 99.60 0.56 15.06 one hundred.40 1.05 14.97 99.80 0.85 24.95 99.80 0.90 24.88 99.50 1.25 24.90 99.60 1.aAverage of six determinations.Table 6: Determination of MXF in its pharmaceutical dosage forms applying the common addition strategy.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )2.BCP2.BPB2.BTB5.MO2.0 six.0 ten 4.0 eight.0 12 2.0 four.0 eight.0 five.0 10Avelox tablets Moxiflox tablets Moxifloxacin tablets Total identified (g mL-1 ) Recovery a SD Total found (g mL-1 ) Recovery SD Total discovered (g mL-1 ) Recovery SD 3.98 99.40 0.56 3.96 99.10 0.62 3.98 99.60 0.48 7.98 99.70 0.83 eight.06 one hundred.70 0.89 7.98 99.80 1.ten 11.89 99.ten 1.20 12.02 100.20 1.26 11.92 99.30 1.17 5.98 99.60 0.61 5.97 99.50 0.35 five.96 99.30 0.36 9.99 99.90 0.84 9.96 99.60 0.60 9.99 99.90 0.63 14.07 one hundred.50 1.14 13.99 99.90 0.85 14.08 one hundred.60 1.36 three.98 99.50 0.48 three.97 99.20 0.33 four.01 one hundred.20 0.61 five.95 99.20 0.92 5.99 99.80 0.65 five.96 99.30 0.84 10.04 100.40 1.17 ten.01 one hundred.10 0.93 9.95 99.50 1.07 9.91 99.ten 0.42 9.94 99.40 0.37 9.95 99.50 0.45 15.08 100.50 0.76 15.03 one hundred.20 0.75 14.97 99.80 0.85 19.90 99.50 1.16 19.92 99.60 1.28 19.83 99.15 0.Journal of Analytical Methods in ChemistryaAverage of six determinations.Journal of Analytical Strategies in ChemistryTable 7: Determination of ENF in its pharmaceutical dosage types applying the normal addition approach. ReagentTaken (g mL-1 ) Pure drug added (g mL-1 ) five.0 BCG five.0 BBTBa5.0 ten 15 5.0 10Enrocin ten injectable Avitryl 20 injectable Total located (g mL-1 ) Recovery a SD Total found (g mL-1 ) Recovery SD 9.92 99.20 0.48 9.94 99.40 0.46 14.94 99.60 0.66 15.20 one hundred.10 0.72 19.98 ten.05 14.91 19.84 99.90 0.82 one hundred.50 0.56 99.40 0.83 99.20 1.20 19.90 9.97 15.05 19.82 99.50.